Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are controversies about the best sites -biopsy based -tests for H pylori associated gastritis. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy

NCT06269380

Gastritis H Pylori Gastritis Chronic Intestinal Metaplasia

COMPLETED NA

Helicobacter Pylori Gastritis and Its Relation to Metabolic Syndrome Components

NCT06935955

Gastritis

NOT_YET_RECRUITING

Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric Carcinoma

NCT05811546

Gastric Carcinoma

UNKNOWN

Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis

NCT05073614

Chronic Gastritis

COMPLETED NA

Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

NCT05444439

H Pylori Infection

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia. 400 patients with dyspepsia are planned to be enrolled in this study. in addition to the routine antral biospy, corpus biospies are taken to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Helicobacter Pylori Gastric Antrum CORPUS BIOPSIES

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ENDOSCOPIC GASTRIC BIOPSIES

ENDOSCOPIC BIOPSEIS TAKEN FROM BOTH ANTRUM AND CORPUS FOR H PYLORI DETECTION

Group Type OTHER

ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

Intervention Type OTHER

ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients included in this study are those with peptic ulcer disease, previous upper gastrointestinal surgery, a known or a suspected past history of H.pylori eradication therapy, a personal or first-degree family history of gastric cancer